Your session is about to expire
← Back to Search
Surgical Device
Surgical Devices for Neural Tube Defects
N/A
Recruiting
Led By Michael A Belfort, MD
Research Sponsored by Michael A Belfort
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediate post-procedure period (until the leave the or)
Awards & highlights
Study Summary
This trial tests the safety & effectiveness of tools used to fix birth defects in unborn babies.
Who is the study for?
This trial is for patients choosing to have fetoscopic repair for neural tube defects like Spina Bifida. It's not open to those who decide against this specific type of fetal surgery.Check my eligibility
What is being tested?
The study is testing the safety and effectiveness of modified surgical tools, including special sheaths and irrigators, used during fetoscopic repair procedures for neural tube defects.See study design
What are the potential side effects?
Since this trial focuses on devices rather than drugs, side effects may include complications from surgery such as infection or damage to surrounding tissues.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediate post-procedure period (until the leave the or)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediate post-procedure period (until the leave the or)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of adverse events
Number of device defects, malfunctions, or failures
Trial Design
1Treatment groups
Experimental Treatment
Group I: Modified Devices in fetoscopic NTD repairExperimental Treatment1 Intervention
Single arm study. All patients will undergo fetoscopic NTD repair with the use of the modified devices.
Find a Location
Who is running the clinical trial?
Michael A BelfortLead Sponsor
4 Previous Clinical Trials
405 Total Patients Enrolled
Baylor College of MedicineOTHER
1,002 Previous Clinical Trials
6,002,704 Total Patients Enrolled
3 Trials studying Neural Tube Defects
99 Patients Enrolled for Neural Tube Defects
Michael A Belfort, MDPrincipal InvestigatorBaylor College of Medicine and Texas Children's Hospital
1 Previous Clinical Trials
300 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am choosing to have surgery for a spinal defect in my unborn baby.I have chosen not to have surgery for a fetal condition before birth.
Research Study Groups:
This trial has the following groups:- Group 1: Modified Devices in fetoscopic NTD repair
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many individuals have signed up for this clinical research initiative?
"Affirmative. Information hosted on clinicaltrials.gov demonstrates that this research endeavour, which was first advertised on November 14th 2022, is actively seeking participants. 100 people need to be enrolled from 1 various medical facilities."
Answered by AI
Are there any open slots available in this clinical research project?
"This clinical trial is currently in the process of enrolling participants. According to the information posted on clincialtrials.gov, it was first made available on November 14th 2022 and has been recently modified on January 3rd 2023."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger